Indeed, the identification of a clearly inactivating TSC1 or TSC2 mutation is considered sufficient evidence for a diagnosis of TSC, even in the absence of clinical signs [Northrup et al., 2013]. This evidence concerns the gene TSC1 and tuberous sclerosis.